Body composition measurement using computed tomography: Does the phase of the scan matter?

Nutrition

Volumn 41, Issue , 2017, Pages 37-44

  Rollins, Katie E ^a   Javanmard Emamghissi, Hannah ^a   Awwad, Amir ^b   Macdonald, Ian A ^b   Fearon, Kenneth C H ^c   Lobo, Dileep N ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Arterial; Body composition; Computed tomography; Contrast enhanced scan; Myosteatosis; Noncontrast scan; Portovenous; Sarcopenia

Indexed keywords

ADIPOSE TISSUE; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; FAT FREE MASS; FAT MASS; FEMALE; HUMAN; IMAGE ANALYSIS; INTERRATER RELIABILITY; INTRAMUSCULAR ADIPOSE TISSUE; INTRAPERITONEAL FAT; MAJOR CLINICAL STUDY; MALE; MEAN SKELETAL MUSCLE HOUNSFIELD UNIT; MUSCULOSKELETAL SYSTEM PARAMETERS; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE INDEX; SUBCUTANEOUS FAT; THIRD LUMBAR VERTEBRA; X-RAY COMPUTED TOMOGRAPHY; ABDOMINAL RADIOGRAPHY; DIAGNOSTIC IMAGING; IMAGE ENHANCEMENT; IMAGE PROCESSING; OBSERVER VARIATION; PROCEDURES; REPRODUCIBILITY; SKELETAL MUSCLE;

CONTRAST MEDIUM;

BODY COMPOSITION; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MUSCLE, SKELETAL; OBSERVER VARIATION; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHY, ABDOMINAL; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85020317081     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2017.02.011     Document Type: Article

References (26)

1. Tamandl, D., Paireder, M., Asari, R., Baltzer, P.A., Schoppmann, S.F., Ba-Ssalamah, A., Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26 (2016), 1359–1367.
2. Martin, L., Birdsell, L., Macdonald, N., Reiman, T., Clandinin, M.T., McCargar, L.J., et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31 (2013), 1539–1547.
3. Antoun, S., Baracos, V.E., Birdsell, L., Escudier, B., Sawyer, M.B., Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 21 (2010), 1594–1598.
4. Akahori, T., Sho, M., Kinoshita, S., Nagai, M., Nishiwada, S., Tanaka, T., et al. Prognostic significance of muscle attenuation in pancreatic cancer patients treated with neoadjuvant chemoradiotherapy. World J Surg 39 (2015), 2975–2982.
5. Joglekar, S., Nau, P.N., Mezhir, J.J., The impact of sarcopenia on survival and complications in surgical oncology: a review of the current literature. J Surg Oncol 112 (2015), 503–509.
6. Prado, C.M., Baracos, V.E., McCargar, L.J., Reiman, T., Mourtzakis, M., Tonkin, K., et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 15 (2009), 2920–2926.
7. Prado, C.M., Lieffers, J.R., McCargar, L.J., Reiman, T., Sawyer, M.B., Martin, L., et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9 (2008), 629–635.
8. Goodpaster, B.H., Thaete, F.L., Kelley, D.E., Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci 904 (2000), 18–24.
9. Aubrey, J., Esfandiari, N., Baracos, V.E., Buteau, F.A., Frenette, J., Putman, C.T., et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf) 210 (2014), 489–497.
10. Lee, S., Janssen, I., Ross, R., Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. J Appl Physiol 97 (2004), 948–954.
11. Vehmas, T., Kairemo, K.J., Taavitsainen, M.J., Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord 20 (1996), 570–573.
12. Kodama, Y., Ng, C.S., Wu, T.T., Ayers, G.D., Curley, S.A., Abdalla, E.K., et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188 (2007), 1307–1312.
13. Sala, A., Webber, C., Halton, J., Morrison, J., Beaumont, L., Zietak, A., et al. Effect of diagnostic radioisotopes and radiographic contrast media on measurements of lumbar spine bone mineral density and body composition by dual-energy x-ray absorptiometry. J Clin Densitom 9 (2006), 91–96.
14. Miljkovic, I., Zmuda, J.M., Epidemiology of myosteatosis. Curr Opin Clin Nutr Metab Care 13 (2010), 260–264.
15. Mitsiopoulos, N., Baumgartner, R.N., Heymsfield, S.B., Lyons, W., Gallagher, D., Ross, R., Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85 (1998), 115–122.
16. Burridge, N.A., Rowbottom, C.G., Burt, P.A., Effect of contrast enhanced CT scans on heterogeneity corrected dose computations in the lung. J Appl Clin Med Phys 7 (2006), 1–12.
17. Kvist, H., Sjostrom, L., Tylen, U., Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes 10 (1986), 53–67.
18. Mourtzakis, M., Prado, C.M., Lieffers, J.R., Reiman, T., McCargar, L.J., Baracos, V.E., A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33 (2008), 997–1006.
19. Rollins, K.E., Tewari, N., Ackner, A., Awwad, A., Madhusudan, S., Macdonald, I.A., et al. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 35 (2016), 1103–1109.
20. Malietzis, G., Lee, G.H., Bernardo, D., Blakemore, A.I., Knight, S.C., Moorghen, M., et al. The prognostic significance and relationship with body composition of CCR7-positive cells in colorectal cancer. J Surg Oncol 112 (2015), 86–92.
21. Malietzis, G., Johns, N., Al-Hassi, H.O., Knight, S.C., Kennedy, R.H., Fearon, K.C., et al. Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg 263 (2016), 320–325.
22. Aust, S., Knogler, T., Pils, D., Obermayr, E., Reinthaller, A., Zahn, L., et al. Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer. PLoS One, 10, 2015, e0140403.
23. Chu, M.P., Lieffers, J., Ghosh, S., Belch, A.R., Chua, N.S., Fontaine, A., et al. Skeletal muscle radio–density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy. PLoS One, 10, 2015, e0127589.
24. Fujiwara, N., Nakagawa, H., Kudo, Y., Tateishi, R., Taguri, M., Watadani, T., et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63 (2015), 131–140.
25. Ismael, S., Savalle, M., Trivin, C., Gillaizeau, F., D'Auzac, C., Faisy, C., The consequences of sudden fluid shifts on body composition in critically ill patients. Crit Care, 18, 2014, R49.
26. Fleischmann, D., How to design injection protocols for multiple detector-row CT angiography (MDCTA). Eur Radiol 15:Suppl 5 (2005), E60–E65.